Alx Oncology Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.39

+0.08 (+6.11%)

As of Sep 28, 10:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +1,751.1% upside

Low Target $15.89

Average Target $25.73

High Target $34.39

Current Price $1.39

Current
$1.39

Target
$25.73

$15.89 $25.73 avg $34.39

Scenario Analysis

Bear Case

$15.89

1,043.2%

Low target

Base Case

$25.73

+1,751.1%

Avg target

Bull Case

$34.39

+2,374.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.66

-47.7% from high

52-Week Low

$1.05

+32.4% from low

Target vs 52W High

$25.73

+867.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%